Literature DB >> 10451009

Typing of Streptococcus pneumoniae: past, present, and future.

J Henrichsen1.   

Abstract

Early works leading to the detection of the pneumococcus and eventually to the appreciation that isolates differed in agglutination and that antisera differed in their capacity to protect against pneumococcal infection in the mouse protection test are reviewed. Studies by researchers from Europe, South Africa, and the United States over nearly five decades led to the introduction of serum therapy. Rapid typing methods thus became very important, and type-specific serum therapy generated a dramatic decrease in the number of deaths from pneumococcal pneumonia. Just before the introduction of sulfonamides and, shortly thereafter, penicillin, the use of horse sera was replaced by the use of rabbit sera for a number of reasons. The present methods of typing comprise the capsular reaction test, latex- and coagglutination, and capillary precipitation, to name the most important; these use a large variety of antisera. Newer methods include the use of DNA probes and DNA sequence-based subtyping.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10451009     DOI: 10.1016/s0002-9343(99)00100-x

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  10 in total

1.  Comparison of the Denka Seiken slide agglutination method to the quellung test for serogrouping of Streptococcus pneumoniae isolates.

Authors:  Cheryl K Shutt; Matthew Samore; Karen C Carroll
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

Review 2.  Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) [Prevenar 13(®)]: profile report.

Authors:  Sean T Duggan
Journal:  Paediatr Drugs       Date:  2012-02-01       Impact factor: 3.022

3.  Multiplex PCR-based reverse line blot hybridization assay to identify 23 Streptococcus pneumoniae polysaccharide vaccine serotypes.

Authors:  Fanrong Kong; Mitchell Brown; Archcna Sabananthan; Xianyu Zeng; Gwendolyn L Gilbert
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

4.  "Dodgy 6As": differentiating pneumococcal serotype 6C from 6A by use of the Quellung reaction.

Authors:  Kim M Hare; Heidi Smith-Vaughan; Michael Binks; In Ho Park; Moon H Nahm; Amanda J Leach
Journal:  J Clin Microbiol       Date:  2009-04-08       Impact factor: 5.948

Review 5.  Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) [prevenar 13®].

Authors:  Sean T Duggan
Journal:  Drugs       Date:  2010-10-22       Impact factor: 9.546

Review 6.  Advances in pneumococcal vaccines: advantages for infants and children.

Authors:  Jolanta Bernatoniene; Adam Finn
Journal:  Drugs       Date:  2005       Impact factor: 9.546

7.  Realtime PCR is more sensitive than multiplex PCR for diagnosis and serotyping in children with culture negative pneumococcal invasive disease.

Authors:  Chiara Azzari; Maria Moriondo; Giuseppe Indolfi; Martina Cortimiglia; Clementina Canessa; Laura Becciolini; Francesca Lippi; Maurizio de Martino; Massimo Resti
Journal:  PLoS One       Date:  2010-02-19       Impact factor: 3.240

8.  Evaluation of the specificity of pneumococcal polysaccharide enzyme-linked immunosorbent assay and the effect of serum adsorption based on standard pneumococcal serogroup- or serotype-specific rabbit antisera.

Authors:  Hans-Christian Slotved; Christina Guttmann; Charlotte Demuth Pedersen; Jasper Neergaard Jacobsen; Karen Angeliki Krogfelt
Journal:  Clin Vaccine Immunol       Date:  2009-07-08

Review 9.  Bacterial meningitis: the impact of vaccination.

Authors:  Nick Makwana; F Andrew I Riordan
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

Review 10.  Antibodies: an alternative for antibiotics?

Authors:  L R Berghman; D Abi-Ghanem; S D Waghela; S C Ricke
Journal:  Poult Sci       Date:  2005-04       Impact factor: 3.352

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.